2018 POC Coagulation Testing Market: Physician Offices, Emergency Rooms, Operating Suites, ICU/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, and Birth Centers - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Dec 18, 2018--The “2018 POC Coagulation Testing Market: Physician Offices, Emergency Rooms, Operating Suites, ICU/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers” report has been added to ResearchAndMarkets.com’s offering.
This report provides a comprehensive analysis of the POC coagulation testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.
This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC coagulation market.
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.
Market Segmentation Analysis
Review of nine POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.
Five-year test volume and reagent sales forecasts for coagulation procedures by market segment:Physician Offices/Group Practices Emergency Rooms Operating/Recovery Suites ICUs/CCUs Cancer Clinics Ambulatory Care Centers Surgery Centers Nursing Homes Birth Centers
Sales and Market Share AnalysisSales and market shares of major coagulation reagent and instrument suppliers.
Current and Emerging ProductsAnalysis of coagulation procedures performed in POC testing locations. Review of leading coagulation analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.
Technology ReviewEmerging technologies and their applications for POC testing. Comprehensive listings of companies developing or marketing coagulation testing technologies and products, by assay.
Competitive AssessmentsAssessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.
Strategic RecommendationsSpecific opportunities for new coagulation instruments and reagent systems with potentially significant market appeal during the next five years. Design criteria for POC testing products. Alternative business expansion strategies. Potential market entry barriers and risks.
Companies MentionedAbbott Accriva Agilent Technologies Becton Dickinson Bio/Data bioMerieux Bio-Rad Cepheid Chrono-Log Corgenix Decode Genetics DiaSorin Eiken Chemical EKF Diagnostics Fujirebio Grifols Helena Laboratories Hologic Horiba Instrumentation Laboratory/Werfen Kyowa Medex Leica Biosystems Lonza Qiagen Roche SDIX Sequenom Siemens Healthineers Sienco Sysmex Takara Bio Thermo Fisher Tosoh Wako
For more information about this report visit https://www.researchandmarkets.com/research/hscz4w/2018_poc?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181218005342/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Diagnostics,Coagulation and Hemostasis Testing,In-Office Testing,Oncology
INDUSTRY KEYWORD: PROFESSIONAL SERVICES CONSULTING
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 12/18/2018 05:28 AM/DISC: 12/18/2018 05:28 AM